{
    "Trade/Device Name(s)": [
        "MESACUP BP180 ELISA Kit",
        "MESACUP BP230 ELISA Kit"
    ],
    "Submitter Information": "MBL International Corporation",
    "510(k) Number": "K071961",
    "Predicate Device Reference 510(k) Number(s)": [
        "K902237",
        "K891098",
        "K891099"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "OEG"
    ],
    "Summary Letter Date": "July 8, 2007",
    "Summary Letter Received Date": "July 24, 2007",
    "Submission Date": "",
    "Regulation Number(s)": [
        "21 CFR 866.5660"
    ],
    "Regulation Name(s)": [
        "Multiple Autoantibodies Immunological Test System"
    ],
    "Analyte Class(es)": [
        "autoimmune",
        "immunology"
    ],
    "Analyte(s)": [
        "Anti BP180 antibodies",
        "Anti BP230 antibodies"
    ],
    "Specimen Type(s)": [
        "Serum"
    ],
    "Specimen Container(s)": [],
    "Instrument(s)/Platform(s)": [],
    "Method(s)/Technology(ies)": [
        "Enzyme-linked immunosorbent assay (ELISA)"
    ],
    "Methodologies": [
        "ELISA"
    ],
    "Submission Type(s)": [
        "Assay",
        "Kit"
    ],
    "Document Summary": "FDA 510(k) summary for MESACUP BP180 and BP230 ELISA Kits for detection of anti-BP180 and anti-BP230 antibodies to aid in bullous pemphigoid diagnosis.",
    "Indications for Use Summary": "Semi-quantitative ELISA for detection of anti BP180 or BP230 antibodies in human serum to aid in the diagnosis of bullous pemphigoid, used with other laboratory and clinical findings.",
    "fda_folder": "Immunology"
}